Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H13ClN4 |
Molecular Weight | 308.765 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NN=C2CN=C(C3=CC=CC=C3)C4=C(C=CC(Cl)=C4)N12
InChI
InChIKey=VREFGVBLTWBCJP-UHFFFAOYSA-N
InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3
Molecular Formula | C17H13ClN4 |
Molecular Weight | 308.765 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:17:53 UTC 2023
by
admin
on
Fri Dec 15 15:17:53 UTC 2023
|
Record UNII |
YU55MQ3IZY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548178
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
DEA NO. |
2882
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
WHO-ATC |
N05BA12
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
NDF-RT |
N0000007542
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
WHO-VATC |
QN05BA12
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
NDF-RT |
N0000175694
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
||
|
NCI_THESAURUS |
C1012
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7111
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
7207
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
100000091908
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
C227
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
DB00404
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
ALPRAZOLAM
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
YU55MQ3IZY
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
3426
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
2118
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
760140
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
596
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | RxNorm | ||
|
SUB05370MIG
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
28981-97-7
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
2611
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
DTXSID4022577
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
136
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
YU55MQ3IZY
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
1015008
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
CHEMBL661
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
D000525
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
Alprazolam
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | |||
|
m1578
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY | Merck Index | ||
|
249-349-2
Created by
admin on Fri Dec 15 15:17:53 UTC 2023 , Edited by admin on Fri Dec 15 15:17:53 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
DERIVATIVE -> PARENT | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
||
|
SOLVATE->ANHYDROUS | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
BINDER->LIGAND |
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
α-Hydroxy alprazolam (α-OHALP) is the minor but pharmacologically active metabolite
MINOR
|
||
|
METABOLITE ACTIVE -> PARENT |
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
4-hydroxy alprazolam (4-OHALP) is the major and pharmacologically less active metabolite [of alprazolam]
MAJOR
|
||
|
METABOLITE LESS ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
UNSPECIFIED
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
UNSPECIFIED
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
RENAL CLEARANCE | PHARMACOKINETIC |
|
|
|||
MAXIMUM TOLERATED DOSE | TOXICITY |
|
ROUTE OF ADMINISTRATION |
|
||
Biological Half-life | PHARMACOKINETIC |
|
EXTENDED-RELEASE |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
ORAL BIOAVAILABILITY | PHARMACOKINETIC |
|
IMMEDIATE-RELEASE PHARMACOKINETIC |
|
||
Tmax | PHARMACOKINETIC |
|
ORAL, IMMEDIATE-RELEASE TABLET |
|
||